Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force.

Journal Article (Review)

This article summarizes the results of recent studies using newer agents, including farnesyl transferase inhibitors, matrix metalloproteinase inhibitors, inhibitors of the epidermal growth factor pathway, antiangiogenic therapeutics by inhibition of vascular endothelial growth factor, and some forms of immunotherapy. Although some results have been disappointing, others seem to be promising, serving as a basis for planned larger trials.

Full Text

Duke Authors

Cited Authors

  • Jafari, M; Abbruzzese, JL

Published Date

  • October 2004

Published In

Volume / Issue

  • 13 / 4

Start / End Page

  • 751 - xi

PubMed ID

  • 15350946

Electronic International Standard Serial Number (EISSN)

  • 1558-5042

International Standard Serial Number (ISSN)

  • 1055-3207

Digital Object Identifier (DOI)

  • 10.1016/j.soc.2004.06.009

Language

  • eng